SCHEMBL20340729

SCHEMBL20340729

CCOCc1ccc(OC(=O)C(C)C)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 3/20 0.54
ALOX15 P16050 1/20 0.43
L3MBTL1 Q9Y468 3/20 0.41
LMNA P02545 1/20 0.41
HTR2A P28223 1/20 0.41
PTGS2 P35354 1/20 0.40
PPARA Q07869 1/20 0.40
ADRB2 P07550 1/20 0.39
ADRA2A P08913 1/20 0.39
DRD2 P14416 1/20 0.39
ADRA2C P18825 1/20 0.39
DRD1 P21728 1/20 0.39
ADRA1A P35348 1/20 0.39
DRD3 P35462 1/20 0.39
THRB P10828 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
RXRA P19793 2/20 0.38
RXRB P28702 2/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26417660 0.84 ELANE (0.59) ELANEALOX15LMNAHTR2APTGS2
SCHEMBL14116625 0.82 ELANE (0.61) ELANEALOX15PTGS2PPARAADRB2
SCHEMBL20168323 0.81 ELANE (0.56) ELANEALOX15HTR2APTGS2
SCHEMBL21795326 0.80 ELANE (0.79) ELANEALOX15L3MBTL1LMNAPTGS2
SCHEMBL11295876 0.79 ELANE (0.61) ELANEALOX15LMNAPTGS2PPARA
SCHEMBL19925263 0.79 ELANE (0.61) ELANEALOX15LMNAHTR2APTGS2
SCHEMBL10585377 0.77 ELANE (0.59) ELANEALOX15LMNAHTR2APTGS2
SCHEMBL1097991 0.77 ELANE (0.59) ELANEALOX15LMNAHTR2APTGS2
SCHEMBL27768096 0.77 ELANE (0.59) ELANEALOX15PTGS2ADRB2ADRA2A
SCHEMBL26428982 0.76 TOP2A (0.55) ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10010629-B2 Compositions and methods for in vivo imaging THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2018-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10010629-B2 Compositions and methods for in vivo imaging PLIN3, SGMS1, SGMS2 ELANE 1354/4885ALOX15 168/4885L3MBTL1 1228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.